|
Study of saxagliptin for diabetes shows no increase in heart attack risk. |
 |
 |
|
Health Day News: But the drug had real benefits, as well. "Patients who received saxagliptin also had better control of blood sugar levels and a reduced need for insulin therapy," noted the study's co-principal investigator, Dr. Itamar Raz, of Hadassah Medical Center, Israel. Raz added that the diabetes drug also prevented the progression of microalbuminuria, a condition that occurs when a type of protein called albumin is spilling into the urine due to kidney damage.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
